AAPL
56
3
ALLE
41
9
EMN
48
3
COF
64
2
EXC
69
-3
ISRG
62
3
GOOG
61
6
WAT
48
5
GD
49
-8
ITW
37
4
MNST
57
-2
CA
13
-6
ADI
54
7
DNB
62
12
AN
46
5
APH
70
6
SE
71
3
HSIC
57
3
PEP
47
9
PRU
64
4
AAPL
56
3
ALLE
41
9
EMN
48
3
COF
64
2
EXC
69
-3
ISRG
62
3
GOOG
61
6
WAT
48
5
GD
49
-8
ITW
37
4
MNST
57
-2
CA
13
-6
ADI
54
7
DNB
62
12
AN
46
5
APH
70
6
SE
71
3
HSIC
57
3
PEP
47
9
PRU
64
4
Financhill
Back

Hewlett Packard Enterprise Vs. Alnylam Pharmaceuticals Industry Stock Comparison

Sell
27

HPE
Hewlett Packard Enterprise

Last Price:
$16.53
Seasonality Move:
2.78%
Buy
60

ALNY
Alnylam Pharmaceuticals

Last Price:
$280.77
Seasonality Move:
3.3%
Sell
27
Hewlett Packard Enterprise (HPE) is a Sell

Is Hewlett Packard Enterprise a Buy, Sell or Hold?

  • The current Hewlett Packard Enterprise [HPE] share price is $16.48. The Score for HPE is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
  • HPE is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
60
Alnylam Pharmaceuticals (ALNY) is a Buy

Is Alnylam Pharmaceuticals a Buy, Sell or Hold?

  • The current Alnylam Pharmaceuticals [ALNY] share price is $290.70. The Score for ALNY is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
  • ALNY is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

HPE Stock Price Chart

What is Hewlett Packard Enterprise's stock price today?

  • The Hewlett Packard Enterprise share price today is $16.48
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HPE is experiencing slight buying pressure.

ALNY Stock Price Chart

What is Alnylam Pharmaceuticals's stock price today?

  • The Alnylam Pharmaceuticals share price today is $290.70
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALNY is experiencing selling pressure, which indicates risk of future bearish movement.

HPE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.32 Sell
Relative Strength Index (14 RSI): 37.55 Sell
Chaikin Money Flow: 9763004 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (15.85 - 20.79) Sell
Bollinger Bands (100): (18.71 - 22.93) Sell

ALNY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 3.72 Buy
Relative Strength Index (14 RSI): 71.41 Buy
Chaikin Money Flow: -979016 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (238.44 - 263) Buy
Bollinger Bands (100): (240.32 - 271.8) Buy

HPE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 15.91 Buy
20-day SMA: 17.48 Sell
50-day SMA: 20.26 Sell
200-day SMA: 20.2 Sell
8-day EMA: 16.26 Buy
20-day EMA: 17.36 Sell
50-day EMA: 19.2 Sell
200-day EMA: 19.75 Sell

ALNY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 257.74 Buy
20-day SMA: 249.75 Buy
50-day SMA: 257.54 Buy
200-day SMA: 251.5 Buy
8-day EMA: 263.89 Buy
20-day EMA: 256.08 Buy
50-day EMA: 255.39 Buy
200-day EMA: 243.44 Buy

Hewlett Packard Enterprise Earnings Growth & HPE Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.04 per share, an increase next quarter of $0.04 per share, a decrease this year of $0.15 per share, and an increase next year of $0.28 per share.

Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.91 per share, an increase next quarter of $0.05 per share, an increase this year of $1.08 per share, and an increase next year of $2.75 per share.

Hewlett Packard Enterprise Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Alnylam Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):